NGN Capital

NGN Capital is a venture capital firm that specializes in managing investment funds for the healthcare and biotechnology sectors. The firm strategically deploys capital into companies developing drug products, medical devices, and other biomedical innovations, focusing on opportunities across North America and Europe. Their approach centers on identifying and supporting ventures with significant growth potential within the life sciences landscape.

The firm was established in 2003. Kenneth S. Abramowitz is a co-founder and Managing General Partner, bringing a depth of experience in healthcare investments to the firm's inception. NGN Capital was founded on the insight that targeted investment in the rapidly evolving healthcare and life sciences industries could yield substantial returns while advancing critical medical solutions.

NGN Capital's portfolio comprises innovative companies operating across the healthcare continuum. Their vision is to foster the development and growth of ventures that address unmet medical needs and advance healthcare solutions globally. The firm is dedicated to driving progress by supporting companies poised to make a substantial impact on patient care and overall industry innovation.